holds J&J decision off on psoriasis 1-FDA - UPDATE Reuters drug

have Johnson new require Johnson the until will said regulators making they drug receive psoriasis ustekinumab decision a NEW Friday Dec - U.S. (Reuters) experimental on information, & held on company's YORK, not but off risk-mitigation certain 19 ... ...

Read More...